A novel dynamic risk score to predict venous thromboembolism (VTE) recurrences after 3 months of anticoagulation in patients with incident VTE and without active cancer

被引：0

作者：

Cohen, A. ^{[1
]}

Choudhuri, S. ^{[2
]}

Khan, I ^{[3
]}

Pollock, K. ^{[4
]}

Bober-Irizar, M. ^{[5
]}

Galias, Z. ^{[6
]}

Irizar, A. ^{[5
]}

Bober, M. ^{[7
]}

机构：

[1] Guys & St Thomas NHS Trust Hosp, London, England

[2] Northern Care Alliance NHS Fdn Trust, Manchester, England

[3] Pfizer Ltd, Tadworth, England

[4] Bristol Myers Squibb, London, England

[5] ForecomAI, London, England

[6] AGH Univ Sci & Technol, Krakow, Poland

[7] Univ Surrey, Fac Hlth & Med Sci, Guildford, England

来源：

EUROPEAN HEART JOURNAL | 2024年 / 45卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[11] The incidence of recurrent venous thromboembolism (VTE) and bleeding depending on practical treatment pattern of anticoagulation in the cancer patients with VTE
Bang, S-M.
Kang, J-H.
Hong, M. H.
Ahn, J. S.
Oh, S. Y.
Baek, J. H.
Choi, Y. J.
Shin, S. H.
Kim, Y-J.
Cha, J-H.
Lee, J.
ANNALS OF ONCOLOGY, 2018, 29
[12] Venous thromboembolism (VTE) risk stratification in hospitalized cancer patients
Hijjawi, S. B.
Jallad, S. G.
Ababneh, B. A.
Abdel-Razeq, H. N.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 797 - 797
[13] Venous Thromboembolism (VTE) Recurrence in Patients with Recurrent/Metastatic Solid Cancer Receiving Anticoagulation Therapy After Index VTE; Findings From Korean VTE Registry
Yhim, Ho-Young
Jang, Moon Ju
Choi, Won-Ii
Lee, Jeong-Ok
Lee, Keun-Wook
Kim, Sung Hyun
Kim, Yeo-Kyeoung
Chang, Hye Jung
Kwak, Jae-Yong
Oh, Doyeun
BLOOD, 2011, 118 (21) : 1439 - 1439
[14] Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors
Wun, Ted
White, Richard H.
CANCER INVESTIGATION, 2009, 27 : 63 - 74
[15] Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk
Liebman, Howard A.
THROMBOSIS RESEARCH, 2018, 164 : S19 - S22
[16] Risk Score For Venous Thromboembolism (VTE) In Ambulatory Patients: Impact Of Cancer Type and Risk Score On VTE Incidence, Early Mortality and Progression-Free Survival
Kuderer, Nicole M.
Khorana, Alok A.
Francis, Charles
Culakova, Eva
Lyman, Gary H.
BLOOD, 2013, 122 (21)
[17] Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score (vol 44, pg 1231, 2023)
de Winter, Maria A.
Buller, Harry R.
Carrier, Marc
Cohen, Alexander T.
Hansen, John-Bjarne
Kaasjager, Karin A. H.
Kakkar, Ajay K.
Middeldorp, Saskia
Rasko, Gary E.
Sorensen, Henrik T.
Visseren, Frank L. J.
Well, Philip S.
Dorresteij, Jannick A. N.
Nijkeuter, Mathilde
EUROPEAN HEART JOURNAL, 2024, 45 (29) : 2630 - 2630
[18] Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale
Cohen, Alexander T.
Keshishian, Allison
Lee, Theodore
Wygant, Gail
Rosenblatt, Lisa
Hlavacek, Patrick
Mardekian, Jack
Wiederkehr, Daniel
Sah, Janvi
Luo, Xuemei
BLOOD, 2019, 134
[19] The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE
Yhim, Ho-Young
Jang, Moon Ju
Kwak, Jae-Yong
Yim, Chang-Yeol
Choi, Won-Il
Lee, Yong Cheol
Lee, Jeong-Ok
Lee, Keun-Wook
Bang, Soo-Mee
Kim, Sung-Hyun
Kim, Yeo-Kyeoung
Chang, Hye Jung
Oh, Doyeun
THROMBOSIS RESEARCH, 2013, 131 (04) : E133 - E140
[20] Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure
Lyman, G. H.
Wang, Y.
Wang, H.
Cohen, A. T.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S222 - S222

← 1 2 3 4 5 →